Evidence map›Paper›PMID 30146391›Full record

ArticleCell host & microbe2018

Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination.

Sara B Cohen, Benjamin H Gern, Jared L Delahaye, Kristin N Adams, Courtney R Plumlee, Jessica K Winkler, David R Sherman, Michael Y Gerner, Kevin B Urdahl

Open access · greenAbstract read
In one paragraph

Article in Cell host & microbe, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 376 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
376citing papers in PubMed, 2 pooled it
25.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

376 citing papers in PubMed, 2 syntheses or guidelines pooled it, 580 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. A specialized CD107aiScience · 2026
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Antigen-experienced airway CD8Science advances · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Restricted MHC-II trafficking inbioRxiv : the preprint server for biology · 2026
    Article
  16. Article
  17. Review
  18. The lung tissue environment inbioRxiv : the preprint server for biology · 2026
    Article
  19. Article
  20. Article

316 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sara B CohenCenter for Infectious Disease Research, 307 Westlake Avenue North, Suite #500, Seattle, WA 98109, USA.
Benjamin H GernCenter for Infectious Disease Research, 307 Westlake Avenue North, Suite #500, Seattle, WA 98109, USA; Department of Pediatrics, Division of Infectious Diseases, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, WA 98195, USA.
Jared L DelahayeCenter for Infectious Disease Research, 307 Westlake Avenue North, Suite #500, Seattle, WA 98109, USA; Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.
Kristin N AdamsCenter for Infectious Disease Research, 307 Westlake Avenue North, Suite #500, Seattle, WA 98109, USA.
Courtney R PlumleeCenter for Infectious Disease Research, 307 Westlake Avenue North, Suite #500, Seattle, WA 98109, USA.
Jessica K WinklerCenter for Infectious Disease Research, 307 Westlake Avenue North, Suite #500, Seattle, WA 98109, USA.
David R ShermanCenter for Infectious Disease Research, 307 Westlake Avenue North, Suite #500, Seattle, WA 98109, USA; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Michael Y GernerDepartment of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.
Kevin B UrdahlCenter for Infectious Disease Research, 307 Westlake Avenue North, Suite #500, Seattle, WA 98109, USA; Department of Pediatrics, Division of Infectious Diseases, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, WA 98195, USA; Department of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA. Electronic address: kevin.urdahl@cidresearch.org.
University of Washington · USCenter for Infectious Disease Research · USInfectious Disease Research Institute · US

Funding

TRAINING IN MOLECULAR AND CELLULAR BIOLOGYT32GM007270 · NIGMS · UNIVERSITY OF WASHINGTON · PI RAIBLE, DAVID W · 1985 to 2020
$21.0M
Technology CoreU19AI106761 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI SHERMAN, DAVID R, ZAK, DANIEL E · 2013 to 2017
$18.9M
Technology CoreU19AI135976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADEREM, ALAN A · 2018 to 2022
$17.0M
ACADEMIC PEDIATRIC INFECTIOUS DISEASET32HD007233 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI KEVIN B URDAHL · 1985 to 2026
$6.7M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
T regulatory cells and immunity in tuberculosisR01AI076327 · NIAID · UNIVERSITY OF WASHINGTON · PI URDAHL, KEVIN B · 2009 to 2018
$4.5M
The Roles of Lymphoid Tissue Microenvironments in Guiding the Immune ResponseR01AI134713 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gerner · 2018 to 2026
$4.4M
Eliciting lung-localized CD4 T cell responses against Mycobacterium tuberculosis in preventive and post-exposure settingsR01AI134246 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI LINDENSTRØM, THOMAS, URDAHL, KEVIN B · 2017 to 2021
$3.3M
Micro-anatomical organization of innate and adaptive immune responsesK22AI108628 · NIAID · UNIVERSITY OF WASHINGTON · PI GERNER, MICHAEL · 2016 to 2017
$270k
The role of vitamin D receptor signaling in T cells during Mycobacterium tuberculosis infectionF32AI126703 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI COHEN, SARA B · 2017 to 2019
$139k
NIAID NIH HHS F32 AI126703NIAID NIH HHS K22 AI108628NIAID NIH HHS R01 AI076327NIAID NIH HHS R01 AI134246NIAID NIH HHS R01 AI134713NIAID NIH HHS T32 AI007509NIAID NIH HHS U19 AI106761NIAID NIH HHS U19 AI135976NICHD NIH HHS T32 HD007233NIGMS NIH HHS T32 GM007270
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) infection is initiated in the distal airways, but the bacteria ultimately disseminate to the lung interstitium. Although various cell types, including alveolar macrophages (AM), neutrophils, and permissive monocytes, are known to be infected with Mtb, the initially infected cells as well as those that mediate dissemination from the alveoli to the lung interstitium are unknown. In this study, using a murine infection model, we reveal that early, productive Mtb infection occurs almost exclusively within airway-resident AM. Thereafter Mtb-infected, but not uninfected, AM localize to the lung interstitium through mechanisms requiring an intact Mtb ESX-1 secretion system. Relocalization of infected AM precedes Mtb uptake by recruited monocyte-derived macrophages and neutrophils. This dissemination process is driven by non-hematopoietic host MyD88/interleukin-1 receptor inflammasome signaling. Thus, interleukin-1-mediated crosstalk between Mtb-infected AM and non-hematopoietic cells promotes pulmonary Mtb infection by enabling infected cells to disseminate from the alveoli to the lung interstitium.

Indexed as

AnimalsBacterial ProteinsGranulomaImmunity, InnateInflammationMacrophages, AlveolarMiceMice, Inbred C57BLMice, KnockoutMycobacterium tuberculosisMyeloid Differentiation Factor 88Pulmonary AlveoliReceptors, Interleukin-1TuberculosisBacterial ProteinsEspI protein, Mycobacterium tuberculosisMyd88 protein, mouseMyeloid Differentiation Factor 88Receptors, Interleukin-1alveolar macrophagesESX-1granulomaIL-1innate immunitylungpulmonary tuberculosis

Identifiers

PMID30146391
PMCPMC6152889
OpenAlexW2888406753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.